reSee.it - Related Video Feed

"They're lacking bifidobacteria." "Is that why they're craving sugar? Because they're not absorbing." "and also because the sugar is not getting into the cells, the Krebs cycle is not working." "So now the sugar is going all over the blood, and it's creating these kids that are super hyper and and and, possibly aggressive." "loss of bifidobacteria that basically got these kids to get into this position. Pre diabetes." "loss of bifidobacteria was actually linked with Alzheimer's and Parkinson's." "it's really about reinstating the balance in the gut." "we're killing microbes, which got these kids to begin with to have this condition." "once you stop the killing, you know, you're you're seeing some lights."

The speaker conducted a study on the effects of vaccines on the microbiome. They found that the Bifidobacteria, an important microbe for immunity, decreased in patients after vaccination. This led them to believe that the vaccine may be creating a bacteriophage or bifidophage that kills off certain microbes. They also noticed a lack of bifidobacteria in newborns born to vaccinated mothers, which could potentially be linked to conditions like autism. The speaker emphasized the importance of studying the microbiome in various diseases and the need to understand what is causing the loss of bifidobacteria. They conducted their own research and discovered that many products claiming to contain bifidobacteria actually did not. Overall, the speaker highlighted the need for further research in this area.

Speaker 0 asks: first, what impacts the loss of bifidobacterium? and second, what can we do to replenish it and keep it strong and populated? Speaker 1 responds that the microbiome is still in its infancy, and urges not to assume you can test your stools in the market because the FDA doesn’t have a test approved for testing stool. Regarding buying Bifidobacterium, he says that the problem with replenishing is you may suppress your own ability to make Bifidobacteria, and what Bifidobacteria needs is good nutrition, good vitamins, and good yogurt. He cites the case of a woman who lived to 117 years old in India, noting that remnants of bifidobacteria were found in her stools, and that she ate yogurt three times a day. When asked how much she ate, he replies that there aren’t studies on that, but yogurt is happening. Speaker 1 continues: in a world where we constantly dodge viruses, parasites, and bacteria that secrete toxins, survival involves doing one’s best. There are things that kill the microbiome, notably antibiotics. Therefore, when you take antibiotics, that’s the time to supplement with a good probiotic and good vitamins. He notes a problem: 16 out of 17 probiotics on the market do not have Bifidobacteria. He explains why he began focusing on Bifidobacteria: in the trillion-dollar probiotic industry, if you turn a bottle around and read the ingredients, the bacteria listed are Bifidobacteria. That observation during the pandemic sparked his interest in Bifidobacteria. He says the whole path is to save the Biff, referencing the idea that during stressful moments—political division, hate, anger—seeing the power of a microbe becomes important.

The speaker conducted a study on the impact of vaccines on the microbiome. They found a decrease in Bifidobacteria in patients post-vaccination, suggesting a potential link to the vaccine. Further research showed persistent damage to the microbiome even months later. Additionally, newborns of vaccinated mothers had no Bifidobacteria in their microbiome, raising concerns about the transfer of spike proteins through breast milk.

The speaker conducted a study on the effects of vaccines on the microbiome. They found that the Bifidobacteria, an important microbe for immunity, decreased in patients after vaccination. This led them to believe that the vaccine may be creating a bacteriophage that kills off certain microbes. They also observed a lack of Bifidobacteria in newborns born to vaccinated mothers, which could potentially be linked to autism. The speaker emphasized the importance of studying the microbiome in various diseases and highlighted the need to investigate what is causing the loss of Bifidobacteria. They shared their personal experience of trying to increase their Bifidobacteria through kefir but finding that many products claiming to contain it did not. This led them to further research and experimentation.

"in New Jersey, the rate of autism is one in thirty three, and we we are seeing a depletion of the microbiome." "New Jersey, one in thirty three." "one in ten thousand." "What happens in thirty years from now? Is it gonna be one in one?" "will there be a child born in this country that doesn't have autism?" "the disappearing microbes that I like to call the bifidobacteria disappearance." "I I told you at the beginning, bifidobacteria is important in helping us break down sugars." "What happens when it disappears? Right?" "You're going to have increased MECFS, right? Because they're tired." "MECFS have lots of bifidobacteria."

The speaker conducted a study on the effects of vaccines on the microbiome. They found that the bifidobacteria, an important microbe for immunity, decreased in patients after vaccination. This led them to suspect that the vaccine may be causing the loss of bifidobacteria. They also discovered that newborns born to vaccinated mothers had no bifidobacteria in their microbiome, which raised concerns about the spike protein in breast milk. The speaker connected this research to their work on autism, where a loss of bifidobacteria is common. They emphasized the importance of studying the microbiome in various diseases and published posters on the loss of bifidobacteria in Crohn's and Lyme patients. The speaker hopes for further research to prove their hypothesis.

"everybody is different." "We all have a fingerprint of our microbiome." "families are different." "the mom with triplets had an overgrowth of a certain group of microbes and the triplets, two of the triplets didn't have that microbe, but the one with autism had twice the amount of microbes that the mom had." "Engraftment determines success of a fecal transplant." "The kid started speaking, verbalizing." "We discovered that those people that had severe COVID had zero Bifidobacteria." "autistic kids have loss of bifidobacteria." "two identical twins, same exact microbes disappeared after nine months, and the Bifidobacteria goes up." "these kids are verbalizing, they're reading, they're counting." "Restoring the microbiome, saving the Bif, improving the bifidobacteria, and the kids are verbalizing." "this is a new revelation." "And I think it's going to be one of the biggest discoveries of this century in my opinion."

The speaker reflects on the pandemic, describing it as a time of “miracles,” including not losing anyone and continuing to speak today, despite controversy surrounding her research. She emphasizes that the controversy has hindered the advancement of research and science, urging instead to ask questions as science is about questioning and pushing narratives. She asserts a specific finding: the spike protein reduces bifidobacteria. She explains that the vaccine caused bifidobacteria to die within a month, but the effect persisted, with data indicating zero bifidobacteria in long-COVID or vaccine-injured cases. She notes she has been dealing with this for five years and asserts that people with zero bifidobacteria experience ongoing loss of microbiome diversity and immunity, resulting in poor immunity. She highlights bifidobacteria’s role in absorbing sugar, and adds that another microbe responsible for calcium absorption is also destroyed, leading to impaired calcium uptake. From these observations, she links cellular-level consequences to mitochondrial function, describing how a lack of sugar and calcium results in energy shortfalls and a disrupted Krebs cycle, implying mitochondrial dysfunction. She concludes that long COVID is a spike protein injury and that in many cases these individuals have zero bifidobacteria whether due to the treatment, the virus, or the spike protein itself. She also notes that some patients still have residual COVID in their stools, underscoring the need to pay attention to this finding. Key points emphasized: - The pandemic featured perceived miracles and ongoing controversy around research and vaccines, which the speaker argues stifles scientific progress. - A claim that the spike protein reduces bifidobacteria; the vaccine allegedly kills bifidobacteria within a month, with long-COVID or vaccine-injured individuals showing zero bifidobacteria across the line. - Zero bifidobacteria is linked to loss of microbial diversity, compromised immunity, and poor immune function. - Bifidobacteria’s role in absorbing sugar and a related microbe’s role in calcium absorption are highlighted as critical, with their destruction affecting cellular energy and mitochondrial function. - Long COVID is described as a spike protein injury, with some cases having residual COVID in stools, suggesting the need for attention to these microbial findings.

The speaker conducted a study on the effects of vaccines on the microbiome. They found that the bifidobacteria, an important microbe for immunity, decreased in patients after vaccination. This led them to suspect that the vaccine may be causing the loss of bifidobacteria. They also observed that newborns born to vaccinated mothers had no bifidobacteria in their microbiome, which raised concerns about the spike protein in breast milk. The speaker connected this research to their work on autism, where a loss of bifidobacteria is common. They emphasized the importance of studying the microbiome in various diseases and published posters on the loss of bifidobacteria in Crohn's and Lyme patients. The speaker hopes for further research to prove their hypothesis.

The speaker conducted a study on the effects of vaccines on the microbiome. They found that the Bifidobacteria, an important microbe for immunity, decreased in patients after vaccination. This led them to believe that the vaccine may be creating a bacteriophage or bifidophage that kills off certain microbes. They also noticed a lack of bifidobacteria in newborns born to vaccinated mothers, which could potentially be linked to conditions like autism. The speaker emphasized the importance of studying the microbiome in various diseases and highlighted the need to investigate what is causing the loss of bifidobacteria. They conducted their own research and discovered that some products claiming to contain bifidobacteria did not actually have it. Research is ongoing to further explore these findings.

"My job, I know my job, my job is to wake up humanity to the microbiome and the fact that humanity is going extinct." "look in 1970, the rate of autism was one in ten thousand." "Now it's one in thirty in some areas of the country. California, one in twelve point five boys have autism." "twenty five percent of newborns are born with adequate levels of good bacteria." "out of 4,000 stool samples, less than five percent have bifidobacteria, which is an important microbe that helps us break down sugars." "So, you know, what happens when one in one kid has autism? What happens when there's no more bifidobacteria on the planet because we've destroyed it all? We stop living. That's it."

Out of a thousand samples analyzed in the last year, less than 5% had bifidobacteria, and one out of a thousand stool samples had lactobacillus. Both are believed to be very important microbes. The speaker poses the question of what happens when Bifidobacteria and lactobacillus disappear. They claim you can't absorb sugar or calcium, and asks what happens to the Krebs cycle and humanity. They suggest the loss of bifida bacteria may be linked to chronic disease.

Speaker 0 and Speaker 1 describe findings from studying COVID and the gut microbiome, focusing on bifidobacteria. They state that their lab was the one to detect COVID in stool samples. Their central questions were what COVID does to the microbiome and how long the virus remains in the gut. They observed that one patient had COVID for up to 45 days after respiratory symptoms resolved, and another case showed the virus detectable for up to a year and a half after respiratory symptoms ended. This led them to investigate differences between people who do and do not get COVID, including households with similar exposures. A key observation was linked to bifidobacteria. They note that a difference between individuals who stayed healthy and those who contracted COVID was the level of bifidobacteria. They point out that bifidobacteria are the bacteria commonly advertised as probiotics, present in newborns and that aging is associated with its decline. They emphasize bifidobacteria as an important microbe for the microbiome and its potential role in health outcomes. The discussion includes an example: a farmer who kissed his COVID-positive wife and did not get COVID himself had high microbial diversity and a good amount of bifidobacteria, suggesting resilience due to microbial composition, including bifidobacteria. They extend the implication to mental health, noting that loss of bifidobacteria has been observed in anxiety and bipolar disorder, while acknowledging this is not the only microbe involved in those conditions. Another function attributed to bifidobacteria is aiding digestion: they help break down food to release sugars that enter cells, and assist in releasing calcium. The speakers contrast this with the broader focus on mitochondria and mitochondrial function, arguing that gut microbes initiate the process by breaking down food in the bowels to supply sugars and calcium for cellular processes. In summary, their findings indicate that people with higher bifidobacteria are more resilient to COVID and healthier, whereas those with lower bifidobacteria correlate with greater vulnerability; bifidobacteria play a role in sugar absorption, calcium release, and overall metabolic and potentially mental health outcomes. Speaker 1 and Speaker 0 confirm: people with more bifidobacteria were more resilient and did not get sick from COVID, while those who got very sick did not have enough bifidobacteria or had low levels.

Bifidobacteria is presented as a common denominator lacking in individuals with autism, Alzheimer's, cancer, anxiety, bipolar disorder, obesity, and diabetes. The speaker questioned why young people were less affected by COVID-19 compared to older, diabetic, or obese individuals, and also why some seemingly healthy individuals with autoimmune conditions were severely affected. The speaker had pre-pandemic microbiome data and observed a correlation between bifidobacteria levels and COVID-19 outcomes. High-risk individuals exposed to COVID-19 who never contracted the virus had high levels of bifidobacteria, while those who contracted the virus multiple times had zero bifidobacteria. This observation reinforced the importance of bifidobacteria, further emphasized by treatment outcomes.

The speaker highlights a widespread loss of Bifidobacteria across conditions. "Lyme disease had zero bifidobacteria." "Crohn's patients, zero bifidobacteria." "Alzheimer's patients, zero bifidobacteria." "Invasive cancer, zero bifidobacteria." When we compare to non invasive cancer, long COVID, zero bifidobacteria. "Bipolar disorder. We talk about mental health, right? Zero bifida bacteria, anxiety." The speaker notes: "Think about all the people that were so anxious during COVID. It was through the roof." It is suggested: "Is it because they killed their bifidobacteria, got the virus, and therefore, the bacteroides went up and caused that anxiety." The closing point: "So, the world of the microbiome really opened up during the pandemic."

Speaker 0 explains that in the probiotic market, one out of 17 probiotics on the market has real bacteria in there, meaning 16 out of 17 say Bifidobacteria on the label but don’t actually have it. He adds that three out of 26 yogurts or drinks that say bifidobacteria on the market have bifidobacteria; the rest do not. He then asks about verification and testing. Speaker 1 asks if there is any way to know by looking at the label, and whether testing exists. Speaker 0 says you can call the lab Progena Biome to test, and there are other labs that do spot checks. He notes another problem: whether the microbe is alive or dead. Bifidobacteria in the gut are anaerobic, so exposing capsules to air may kill them, and stomach acid could also kill them before they reach the gut. He reframes the question: what does dead bacteria do to a live microbiome? He compares it to sleeping with corpses and suggests eventual effects on the microbiome and potential diseases, reflecting his viewpoint. Speaker 0 then raises another issue: by taking probiotics, are you suppressing your own gut production, similar to taking pancreatic enzymes which helps digestion but may shut down the pancreas’s own secretion? He questions whether taking oral enzymes could cause damage by reducing the body's own production. He explains that their approach is research-focused: they test patients with a stool test in the research world, then determine what the probiotic is doing, and implement a protocol with the right probiotic, the right prebiotic, the right bovine, and the right vitamins to see if the patient improves. If it works, great; if not, they reassess why the probiotic didn’t work—whether the probiotic was killed in the gut or interacted with certain bowel areas and became inactivated or transformed. Speaker 0 notes that he doesn’t talk about which probiotics upfront because they are still testing. He mentions several probiotics he is testing and acknowledges that not everybody responds similarly. They must understand why a probiotic works in some patients but not in others. Overall, the discussion centers on probiotic quality, viability, and personalized testing to determine effectiveness, along with concerns about dead bacteria, potential suppression of natural gut processes, and the need for ongoing research to explain variable patient responses.

After observing the vaccine rollout, the speaker began collecting stool samples from vaccinated doctors to analyze the vaccine's impact on the microbiome. Initial analysis of four patients revealed a decrease in Bifidobacteria post-vaccination. This trend continued across 34 patients. The speaker hypothesized that the vaccine might be creating a "Bifidofage." In four patients tracked for 90 days, Bifidobacteria levels dropped from approximately 1,000,000 to zero, and this persisted for up to nine months. The speaker also analyzed the microbiome of newborns breastfed by vaccinated mothers and found an absence of Bifidobacteria, which typically constitutes 90% of a newborn's microbiome. The speaker questions whether the spike protein is transferred through breast milk, impacting the baby's gut and killing the Bifidobacteria.

The speaker conducted a study on the effects of vaccines on the microbiome. They found that the Bifidobacteria, an important microbe, decreased in patients before and after vaccination. This led them to believe that the vaccine may be creating a bacteriophage or bifidophage that kills off certain microbes. They also noticed a lack of bifidobacteria in newborns born to vaccinated mothers, which could potentially be linked to conditions like autism. The speaker emphasized the importance of studying the microbiome in various diseases and highlighted the need to investigate what is causing the loss of bifidobacteria. They conducted their own research and discovered that many products claiming to contain bifidobacteria actually did not. Overall, the speaker emphasized the importance of research in understanding and addressing these issues.

Speaker 1 discusses probiotics and the current state of microbiome science: taking random probiotics may be questionable because the technology of the microbiome is not FDA-approved yet. The reason is that there are many bacteria in the microbiome and we don’t know what they are, what they do, whether they’re good or bad. For example, blotia and Rosaburia are poorly understood; 90% of GI colleagues don’t know blotia is a microbe, and 90% don’t know there’s such a thing as Rosaburia. Historically trained on Klebsiella pneumoniae, E. coli, Salmonella, C. difficile, Clostridium perfringens, but not on nonpathogenic microbes. The question remains: is blotia a good bug or a bad bug, and who has too high or too low levels? This represents the abyss of the microbiome and is still research, not consumer product or standard medical practice. Speaker 1 explains that doctors cannot be told to use a new stool test or to start using microbiome data broadly until researchers reproduce findings and doctors see the data for themselves. The idea is that oncologists may notice correlations, such as loss of bifidobacteria in invasive cancer, and observe improvements in cancer alongside bifidobacteria, which could influence acceptance of the gut-brain or microbiome link. However, such observations need replication to move from incidental findings to established conclusions. An example given is Colleen Kelly at Brown University, who published two cases of alopecia areata with C. difficile where hair grew back after fecal transplant. The question is whether fecal transplant for alopecia areata is valid; however, an academic center trying to reproduce the data could not. The speaker suggests uncertainty about whether a specific microbe caused hair regrowth or if exposure during treatment led to it. Until data are reproduced, no one can claim alopecia areata is improved by fecal transplant or microbiota transplant. Concluding guidance: if you’re healthy, keep doing what you’re doing and do nothing else; if you’re not healthy and have multiple diseases and you’ve tried a probiotic, if it works, continue, but if it doesn’t work, then it’s probably not a great probiotic. The overarching theme is careful interpretation, replication, and recognition that microbiome science is still evolving and not yet ready for universal clinical application.

According to the speaker, Albert Einstein said humanity would only have four years to live if all the bees were destroyed. The speaker believes humanity will only have four years to live if bifidobacteria are destroyed, and claims we are close to that point. The speaker states that after analyzing a thousand stool samples with deep genetic sequencing, bifidobacteria are present in less than five percent of people. The speaker further claims that out of those thousand samples, only about twenty had bifidobacteria present above ten percent, which the speaker finds alarming.

Bifidobacteria are important for immunity, but they are not the only important microbe. The speaker notes that bifidobacteria are the microbe that is disappearing. Analyzing thousands of stool samples, out of 4,000 stool samples, there are only four that can be said with certainty “these are both microbiomes.” Out of the thousand samples analyzed, less than five percent have bifidobacteria. The speaker highlights that loss of bifidobacteria is not universally linked to all conditions. It is present in Alzheimer's disease, with Alzheimer's patients having lots of bifidobacteria; Lyme disease patients also have lots of bifidobacteria. Crohn’s patients that have never been treated have lots of bifidobacteria. In autistic kids, there is enough data now; they showed data initially, and now more data and more labs reproducing that data show that there are lots of bifidobacteria in autism. The speaker mentions that “Loss of bifidobacteria in autism” can be addressed by replenishing bifidobacteria, and refers to this as proof of concept that the judge at the American College of Gastroenterology acknowledged, noting that this is what is needed to advance science to understand. Loss of bifidobacteria was also noticed in patients with invasive cancer. The speaker says they published that data at the American College of Gastroenterology and presented at Digestive Disease Week, showing that if a patient had a non-aggressive cancer, they had a better level of bifidobacteria than a patient with invasive cancer who has zero. Regarding therapeutic implications, the speaker asks whether modulating the gut to improve bifidobacteria is feasible and notes collaboration with multiple centers, including MD Anderson. The implication is to start modulating the gut and improving bifidobacteria in cancer patients rather than relying solely on chemotherapy and immunotherapy. In summary, the research conducted at Progena Biome—a research lab—focuses on bifidobacteria, its variable presence across diseases, its potential replenishment in autism, and its association with cancer progression, highlighting ongoing work to modulate the gut microbiome as a therapeutic strategy.

Speaker 0: Bifidobacteria was absent in kids with autism, that Bifidobacteria was absent in Alzheimer's. Bifidobacteria was absent in long haulers, vaccine injured, Lyme patients, Crohn's patients, invasive cancer. When you look at who has Bifidobacteria, the newborns have a lot of Bifidobacteria, old people have zero Bifidobacteria. Nursing home dying, zero Bifidobacteria. The process of aging is really this loss of Bifidobacteria. Expanded: if you look at and you believe the Bible, you know, people lived a lot longer. In biblical times than we are right now. We're barely making it to seventy, eighty and not really healthy seventy, eighty. You know, the mind starts going. So, is the mind starting to go because of the loss of Bifidobacteria? And, when you start looking at, well, what improves Bifidobacteria, right? So, our lab discovered vitamin C improves Bifidobacteria. Okay. Our lab discovered bovine immunoglobulins, the blood of the cow spun around that clear stuff, provided that the cow is not on a lot of antibiotics, is not given a lot of hormones, is not given like thousands of vaccines. So when you start looking at all that, you start seeing the importance of Bifidobacteria and you start seeing, like even me, you know, with Progena Biome, looking at the stool samples before the pandemic, during the pandemic and after the pandemic, there is a lot of disappearance of Bifidobacteria. Is that why we're having an increase in Alzheimer's, increase in cancer? Have we demolished this bifidobacteria? So, to me, that's a very important microbe that I believe is our longevity, if we can retain it. And it's not easy to retain in a world that's toxic in a way and in a world where we are, you know, put you know, given media full of stress, where we are divided, where we are, you know, constantly nervous of the next pandemic or the next virus, you know, it's it's almost like this bottle that you're shaking and it's full of gas and you just need to put it on the counter and let it just calm down, right? So, I think that's, it's a very important microbe.

After discovering kefir wasn't improving their microbiome, the speaker tested various yogurts and drinks labeled as containing bifidobacteria. Out of 26 drinks tested from a Malibu grocery store, only 3 contained bifidobacteria, despite label claims. The speaker also tested probiotics, finding that 16 out of 17 probiotics claiming to contain bifidobacteria had none. The speaker suggests this is a widespread issue, cautioning consumers that products marketed to improve gut health may not deliver on their promises. The speaker implies that many products are a "gimmick" and do not contain the bifidobacteria they claim to.

The speaker conducted a study on the effects of vaccines on the microbiome. They found that the bifidobacteria, an important microbe for immunity, decreased in patients after vaccination. This led them to suspect that the vaccine may be causing the loss of bifidobacteria. They also observed a lack of bifidobacteria in newborns born to vaccinated mothers, which raised concerns about the spike protein in breast milk. The speaker connected this research to their work on autism, where a loss of bifidobacteria is common. They emphasized the importance of studying the microbiome in various diseases and published posters on the loss of bifidobacteria in Crohn's and Lyme patients. The speaker hopes for further research to prove their hypothesis.